Agila Specialties Pharma Corporation, Canada, which is part of the injectable drug division of Strides Arcolab, a globally renowned generic drug manufacturer, has formed a joint venture (JV) with Jamp Pharma, a Canadian generic drug company, to introduce a variety of quality injectable generic drug in Canada.
This sales and marketing joint venture will operate under the name Agila-jamp Canada Inc in which Agila will hold 70% stake and the remaining 30% by Jamp Pharma. The JV will be headquartered in Boucherville, Quebec.
Agila-jamp will be launching around 40 products in the next 2 years. Many of these products have already been approved by Health Canada and will be immediately launched through local hospital and pharmacists. The existing sales force at Jamp Pharma will be responsible to introduce the entire Agila-Jamp product portfolio.
Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterile injectables.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: